PAXALISIB

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H22N8O2
Molecular Weight	382.4204
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1(C)c2nc3c(nc(-c4c[nH]c(=N)nc4)nc3n2CCO1)N5CCOCC5

InChI

InChIKey=LGWACEZVCMBSKW-UHFFFAOYSA-N

InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21)

HIDE SMILES / InChI

Molecular Formula	C18H22N8O2
Molecular Weight	382.4204
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
PI3-kinase p110-alpha subunit 33 Target ID: CHEMBL4005 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27096040	Inhibitor 7728		2.0 nM [IC50]
Serine/threonine-protein kinase mTOR 32 Target ID: CHEMBL2842 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27096040	Inhibitor 7728		0.07 µM [IC50]

Substance Class	Chemical Created by `admin` on `Sat Jun 26 09:00:45 UTC 2021` Edited by `admin` on `Sat Jun 26 09:00:45 UTC 2021`
Record UNII	P5DKZ70636
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PAXALISIB

Official Name

English

GDC-0084

Preferred Name

English

5-(6,6-DIMETHYL-4-MORPHOLINO-8,9-DIHYDRO-6H-(1,4)OXAZINO(3,4-E)PURIN-2-YL)PYRIMIDIN-2-AMINE

Systematic Name

English

PAXALISIB [USAN]

Common Name

English

G-02441729

Code

English

PAXALISIB [INN]

Common Name

English

G02441729

Code

English

2-PYRIMIDINAMINE, 5-(8,9-DIHYDRO-6,6-DIMETHYL-4-(4-MORPHOLINYL)-6H-(1,4)OXAZINO(4,3-E)PURIN-2-YL)-

Systematic Name

English

GDC0084

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

759220